Get the Stockscreener App
1.265
4.17%
-0.055
After Hours:
1.30
0.035
+2.77%
Inmune Bio Inc Stock (INMB) Forecast
The Inmune Bio Inc (INMB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $24.33, representing a +1,823% increase from the current price of $1.265. The highest analyst price target is $30.66, and the lowest is $18.00.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INMB Price Target
Average 20.48
(+1,519% Upside)
Is Inmune Bio Inc (INMB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.87 | Neutral |
| STOCH(9,6) | 39.76 | Neutral |
| STOCHRSI(14) | 46.43 | Neutral |
| MACD(12,26) | -0.0712 | Buy |
| ADX(14) | 9.7185 | Neutral |
| William %R | -81.41 | Buy |
| CCI(14) | -42.79 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.3245
Sell
|
1.3389
Sell
|
| MA20 |
1.3933
Sell
|
1.3914
Sell
|
| MA50 |
1.5269
Sell
|
1.5167
Sell
|
| MA100 |
1.6429
Sell
|
1.8119
Sell
|
| MA200 |
2.6576
Sell
|
2.8002
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, INMB could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on INMB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.87 indicates that INMB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 39.76 indicates that INMB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.43 indicates that INMB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 9.7185 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -42.79 indicates that INMB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term INMB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Inmune Bio Inc financial reports and earnings history, Inmune Bio Inc (INMB) stock could reach $12.62 by 2030, $10.99 by 2040 and $13.25 by 2050. See the projected annual prices until 2050 of the Inmune Bio Inc stock below:
- Inmune Bio Inc (INMB) is expected to reach an average price of $10.70 in 2035, with a high prediction of $10.79 and a low estimate of $8.0218. This indicates an $746.01% rise from the last recorded price of $1.265.
- Inmune Bio Inc (INMB) stock is projected to chart a bullish course in 2040, with an average price target of $9.3243, representing an $637.10% surge from its current level. The forecast ranges from a conservative $8.533 to a sky-high $10.99.
- Our analysts predict Inmune Bio Inc (INMB) to jump 636.59% by 2045, soaring from $8.7778 to an average price of $9.3178, potentially reaching $11.30. While $8.7778 is the low estimate, the potential upside is significant.
- Inmune Bio Inc (INMB) stock is expected to climb by 2050, reaching an average of $11.56, a $814.02% jump from its current level. However, a wide range of estimates exists, with high and low targets of $13.25 and $9.5924, respectively, highlighting the market's uncertainty.
Inmune Bio Inc Stock (INMB) Year by Year Forecast
Inmune Bio Inc Stock (INMB) Price Forecast for 2026
The predicted value for Inmune Bio Inc (INMB) in 2026 is set at an average of $19.52. Estimates vary from a peak of $31.05 to a trough of $7.9818, indicating an +1,443% surge from the present price of $1.265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $19.92 | $18.00 | $30.66 | +1,475% |
| May, 2026 | $14.60 | $13.27 | $20.24 | +1,055% |
| June, 2026 | $12.45 | $11.59 | $15.36 | +883.80% |
| July, 2026 | $10.46 | $9.9057 | $14.68 | +726.54% |
| August, 2026 | $18.57 | $10.40 | $18.98 | +1,368% |
| September, 2026 | $23.65 | $17.18 | $26.75 | +1,769% |
| October, 2026 | $16.51 | $13.74 | $29.68 | +1,205% |
| November, 2026 | $24.40 | $15.83 | $24.47 | +1,829% |
| December, 2026 | $20.00 | $17.50 | $31.05 | +1,481% |
Inmune Bio Inc Stock (INMB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Inmune Bio Inc (INMB) is $13.19, with a high forecast of $21.06 and a low forecast of $5.3128. This indicates an +942.36% increase from the last price of $1.265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $20.63 | $17.51 | $21.06 | +1,531% |
| February, 2027 | $14.05 | $13.81 | $20.68 | +1,011% |
| March, 2027 | $11.48 | $10.56 | $14.55 | +807.55% |
| April, 2027 | $9.461 | $8.841 | $11.78 | +647.90% |
| May, 2027 | $11.04 | $8.5613 | $11.49 | +772.85% |
| June, 2027 | $8.4722 | $8.3222 | $12.46 | +569.74% |
| July, 2027 | $9.1028 | $6.8625 | $10.53 | +619.59% |
| August, 2027 | $7.5333 | $7.3633 | $9.7732 | +495.52% |
| September, 2027 | $7.484 | $5.3128 | $8.9634 | +491.62% |
| October, 2027 | $7.7645 | $6.9345 | $8.6844 | +513.80% |
| November, 2027 | $10.90 | $7.7846 | $11.06 | +761.27% |
| December, 2027 | $10.10 | $9.2155 | $11.44 | +698.08% |
Inmune Bio Inc Stock (INMB) Price Forecast for 2028
In 2028, Inmune Bio Inc (INMB) is projected to reach an average price of $8.7898, with a high projection of $11.14 and a low estimate of $6.4372. This indicates an +594.85% rise from the last price of $1.265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.8363 | $8.3261 | $10.38 | +598.52% |
| February, 2028 | $6.8868 | $6.7268 | $9.3855 | +444.41% |
| March, 2028 | $8.3575 | $6.4372 | $8.9999 | +560.67% |
| April, 2028 | $7.748 | $7.348 | $8.7278 | +512.49% |
| May, 2028 | $7.7187 | $7.0384 | $8.6286 | +510.17% |
| June, 2028 | $8.5093 | $6.7788 | $10.08 | +572.67% |
| July, 2028 | $10.17 | $7.7594 | $11.09 | +703.94% |
| August, 2028 | $7.6005 | $7.3505 | $11.01 | +500.83% |
| September, 2028 | $7.531 | $6.5609 | $8.1706 | +495.34% |
| October, 2028 | $8.7516 | $7.4714 | $9.6111 | +591.82% |
| November, 2028 | $8.5522 | $7.562 | $9.6917 | +576.07% |
| December, 2028 | $9.7728 | $8.5524 | $11.14 | +672.55% |
Inmune Bio Inc Stock (INMB) Price Forecast for 2029
The 2029 price forecast for Inmune Bio Inc Stock (INMB) is $11.32 on average, with a high prediction of $15.44 and a low estimate of $7.1948. This represents an +794.57% increase from the previous price of $1.265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.2635 | $9.0133 | $11.95 | +632.29% |
| February, 2029 | $8.604 | $8.0739 | $9.6909 | +580.16% |
| March, 2029 | $8.6345 | $8.0942 | $9.6244 | +582.57% |
| April, 2029 | $7.6351 | $7.1948 | $8.7647 | +503.56% |
| May, 2029 | $7.5558 | $7.392 | $8.6252 | +497.29% |
| June, 2029 | $10.31 | $7.3259 | $10.60 | +714.73% |
| July, 2029 | $11.96 | $9.9167 | $12.48 | +845.20% |
| August, 2029 | $12.63 | $10.90 | $14.47 | +898.22% |
| September, 2029 | $13.62 | $11.00 | $15.44 | +976.53% |
| October, 2029 | $12.90 | $11.49 | $14.22 | +919.66% |
| November, 2029 | $9.0693 | $8.9993 | $13.18 | +616.94% |
| December, 2029 | $12.26 | $9.0994 | $13.42 | +869.17% |
Inmune Bio Inc Stock (INMB) Price Forecast for 2030
Inmune Bio Inc Stock (INMB) is expected to reach an average price of $8.0844 in 2030, with a high forecast of $12.62 and a low forecast of $3.5485. This signifies an +539.08% surge from the last price of $1.265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.72 | $9.9206 | $12.62 | +826.59% |
| February, 2030 | $11.07 | $10.20 | $12.01 | +775.29% |
| March, 2030 | $10.17 | $10.00 | $11.05 | +704.23% |
| April, 2030 | $7.3146 | $6.5741 | $10.97 | +478.23% |
| May, 2030 | $7.1136 | $6.8757 | $7.7751 | +462.34% |
| June, 2030 | $6.367 | $4.8468 | $7.1862 | +403.32% |
| July, 2030 | $5.2784 | $5.2084 | $6.6773 | +317.26% |
| August, 2030 | $7.2297 | $5.0887 | $7.4595 | +471.52% |
| September, 2030 | $7.1232 | $6.43 | $7.7303 | +463.10% |
| October, 2030 | $6.3579 | $6.0314 | $7.1508 | +402.60% |
| November, 2030 | $4.4379 | $4.383 | $7.783 | +250.82% |
| December, 2030 | $4.7441 | $3.5485 | $4.799 | +275.03% |
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):